The 2012 UK Infectious Disease Testing Market

  • March 2012
  • -
  • Venture Planning Group

This report presents a comprehensive analysis of the UK infectious disease testing market, including:
  • Major issues pertaining to the UK laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.
  • Current scientific views on the definition, epidemiology, and etiology of major infectious diseases and microorganisms.
  • Ten-year test volume and sales forecasts for nearly 80 infectious disease testing performed in UK hospitals, blood banks, public health and commercial laboratories.
  • Instrumentation technologies and feature comparison of leading analyzers.
  • Sales and market shares of leading suppliers.
  • Emerging diagnostic technologies and their potential market applications.
  • Product development opportunities.
  • Profiles of current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
  • Business opportunities and strategic recommendations for suppliers.
Contains 978 pages and 159 tables

Table Of Contents

Table of Contents

Introduction
Worldwide Market and Technology Overview
A. Major Infectious Disease Tests
1. AIDS
a. Background
Structure and Composition
Classification
Origin of AIDS
Animal Lentivirus Systems
Virus Receptos
HIV Infections in Humans
- Pathogenesis and Pathology: Overview of
HIV Infection Course
CD4T Lymphocytes and Memory Cells
Monocytes and Macrophages
Lymphoid Organs
Neural Cells
Viral Coinfections
- Clinical Findings
Plasma Viral Load
Pediatric AIDS
- Neurologic Disease
- Opportunistic Infections
- Cancer
Immunity
- Virus Isolation
- Serology
- Detection of Viral Nucleic
Acid and Antigens
Infectivity
Epidemiology
- Worldwide Spread of AIDS
- United States
- Routes of Transmission
b. Diagnostic Tests
Laboratory Diagnosis
- Enzyme Immunoassay Interpretation
- Specific, Sensitivity, and Predictive
Value of Enzyme Immunoassays
Competition Assays
Western Blot Technique
Immuno-Fluorescence Assay (IFA)
Radioimmunoprecipitation
HIV-1/HIV-2 Combination Testing
Methods of HIV-Antigen Detection
Antigen Assays and Blood Screening
Urine Tests
Immunopathogenic Mechanism of HIV Infection
DNA Probes
- Overview
- Quantitative Polymerase Chain Reaction
- In Situ PCR
- Needed Improvements
Viral Load/Drug Resistance Testing
Genotype and Phenotype Testing
Blood Banking Consideration
c. Vaccines and Drugs
- Antiviral Drugs
- Vaccines Against HIV
Transmission of HIV in Blood Products
HIV Transmission in Transplant and
Artificial Insemination Recipients
2. Adenovirus
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
d. Adeno-Associated Viruses(AAV)
3. Aeromonas
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
4. Anthrax/Bacillus Anthracis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
5. Arboviruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
6. Babesiosis
a. Background
7. Bacillary Epithelioid Angiomatosis (BEA)
And Other Bartonella (Rochalimaea)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
8. Blastocystis Hominis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
9. Brucella
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
10. Campylobacter
a. Background
b. Diagnostic Tests
Identification from Culture
c. Vaccines and Drugs
11. Candida
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
12. Chagas Disease
a. Background
13. Chancroid
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
14. Chlamydia
a. Background
Chlamydia Psittaci
Chlamydia Pneumoniae
Chlamydia Trachomatis
b. Diagnostic Tests
c. Vaccines and Drugs
15. Clostridium Difficile
a. Background
Pediatric Infections
Epidemiology
b. Diagnostic Tests
Counterimmunoelectrophoresis
Fluorescent-Antibody Assays
Poloymerase Chain Reactions
c. Drugs and Vaccines
16. Coronaviruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
17. Coxsackieviruses
a. Background
Herpangina
Hand-foot-and-mouth syndrome
Hepidemic Conjuctivitis
Pharingitis
Epidemic Pleurodynia
Myodarditis,Pericarditis
Overwhelming Infection of the Newborn
Acute Aseptic Meningitis
Undifferentiated Febrile Illness
Fever with upper respiratory infection
Encephalitis
Asymptomatic Infection
b. Diagnostic Tests
c. Vaccines and Drugs
18. Creutzfeldt-Jakob’s Disease
a. Background
Blood Transmission
b. Diagnostic Tests
Major Commercial and Academic Players
- Bayer
- Disease Sciences/Bio Tec Global
- Imperial College of Medicine
- Ortho-Clinical Diagnostics
- Pall
- ProMetic Life Sciences
- Proteome Sciences/Idexx
- Q-One Biotech
- Serono
- U.S. Agricultural Research Service
c. Vaccines
19. Cryptosporidium Parvum
a. Background
b. Diagnostic Tests
Histologic
Laboratory Parasitology
Serodiagnosis
c. Vaccines and Drugs
20. Cyclospora Cayetanensis
a. Background
Asymptomatic Infection
Diarrhea in Immunocompetent Persons
Diarrhea in Immunocompromisedersons
b. Diagnostic Tests
c. Vaccines and Drugs
21. Cytomegalovirus
a. Background
Chorioretinitis
Gastrointestinal
Central Nervous System Disease
b. Diagnostic Tests
c. Vaccines and Drugs
22. Ebola Virus
a. Background
Epidemiology
Hemorrhagic Fever
b. Diagnostic Tests
c. Vaccines and Drugs
23. E. Coli
a. Background
Role of Escherichia Coli in
Causing Diarrhea
EPEC
ETEC
EIEC
EHEC
b. Diagnostic Tests
c. Vaccines and Drugs
24. EchoVirus
a. Background
Acute Aseptic Miningitisis
Encephalitis
Exanthems
Respiratory Disease
Myope;ricarditis
Neonatal Infections
b. Diagnostic Tests
c. Vaccines and Drugs
25. Encephalitis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
26. Enteroviruses
a. Background
b. Diagnostic Tests
Viral Isolation and Identification
Antibody Tests
c. Vaccines and Drugs
27. Epstein-Barr Virus
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
28. Giardia Lamblia
a. Background
Life Cycle and Morphology
Morphology of Trophozoites
Clinical Disease
b. Diagnostic Tests
c. Vaccines and Drugs
29. Gonorrhea
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
30. Granuloma Inguinale
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
31. Hantavirus
a. Background
Identification of the Agent
Transmission
Other Rodent Hantaviruses
Distribution
Hantavirus Diseases
Epidemiology
Addendum in Proof-Northeastern Connection
Previously Unknown Pathogens
Cases Nationwide
b. Diagnostic Tests
An Immunohistochemistry Approach
Hantavirus Rapid Diagnostic Test
ELISA Diagnosis of Hantavirus Pulmonary
Syndrome
IgG ELISA
IgM Capture ELISA
c. Vaccines and Drugs
32. Helicobacter Pylori
a. Background
Pathogenesis
Role in Peptic Ulcer Disease
Role in Gastric Cancer
Nonulcer Dyspepsia
b. Diagnostic Tests
c. Vaccines and Drugs
Specific Therapeutic Regimens
Who Should Be Treated?
Participants in Controlled Clinical Trials
Patients with Refractory Peptic Ulcer
Patients with Refractory NUD
Patients in High-Risk Groups for Gastric
Cancer
33. Hepatitis
a. Background
b. Hepatitis A
c. Hepatitis B
d. Hepatitis C
Classification
Transmission of Infection
Occupational Hazards
Acute Hepatitis
Diagnosis of Acute Infection
Chronic Hepatitis
HCV and Other Chronic Liver Diseases
Alcoholic Liver Disease
Hepatitis B Coinfection
Cirrhosis and Hepatocellular Carcinoma
Diagnostic Tests
Possible Indications for HCV RNA Testing
Conclusions and Future Direction
e. Hepatitis D
Historical Perspective
Epidemiology
HBV-HDV "Coinfection" vs. "Superinfection"
Methods of Detecting HDV
Prevention
f. Hepatitis E
Background
Prevalence of the Disease
Diagnostic Tests
Epidemiologic Serosurveys
Serologic Cross-Reactivity
g. Hepatitis G
Vaccines and Drugs
34. Herpes Simplex Virus
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
35. Human Herpes Virus-6 (HHV-6)
a. Background
HIV-6 Infections
b. Diagnostic Tests
c. Vaccines and Drugs
36. Influenza Viruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
37. Legionella
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
38. Lyme Disease
a. Background
Clinical Description
Clinical Case Definition
Laboratory Criteria for Diagnosis
Case Classification
b. Diagnostic Tests
c. Vaccines and Drugs
39. Lymphogranuloma Venereum (LGV)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
40. Malaria
a. Background
b. Diagnostic Tests
Potential Diagnositic Problems with Positive
Patients from Non-endemic Areas
- Patient
- Laboratory
- Physician
c. Vaccines and Drugs
41. Measles (Rubeola)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
42. Meningitis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
Development of Polysaccharide Vaccines
Quadrivalent Vaccine Development
Meningococcal A.C.Y. and W-135 Vaccines
Efficacy of Group C Vaccine
Efficacy of Group A Vaccine
Combinations of Group A and C Vaccines
Group B Efficacy Trials
Future Direction
43. Microsporidium
a. Background
Prevalence and Geographic Distribution
Sources of Human Infection and Transmission
b. Diagnostic Tests
Light Microscopic Examination of Stool
Specimens By Chromotrope Staining
Stool Concentration Methods
Chemofluorescent Agents
Giemsa Staining of Stool Specimens
Cytologic Diagnosis
Histologic Examination
Electron Microscopy
Examination of Bodily Fluids
Examination of Tissue Sections
Immunofluorescence Detection Procedures
Serology
Cell Culture
Approach to Diagnosis
Evaluation of Patients with Presumptive
Intestinal Microsporidiosis
Evaluation of Patients with Presumptive
Ocular Microsporidiosis
c. Vaccines and Drugs
44. Mononucleosis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
45. Mumps
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
Efficacy of Vaccination
Future Issues
46. Mycoplasma
a. Background
Ureaplasma Urealyticum and Mycoplasma Hominis
b. Diagnostic Tests
c. Vaccines and Drugs
47. Papillomaviruses
a. Background
HPV in Cancer
Cervical Neoplasm
b. Diagnostic Tests
c. Vaccines and Drugs
Prevention
48. Parvovirus B19
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
49. Pneumonia
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
50. Polyomaviruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
51. Pseudomonas Aeruginosa
a. Background
Virulence Factors
b. Diagnostic Tests
c. Vaccines and Drugs
52. Rabies
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
53. Respiratory Syncytial Virus (RSV)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
54. RhinoViruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
55. RotaVirus (REOVIRUS)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
56. Rubella(MEASLES)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
Developing Countries
Elimination and Eradication of Measles
New Developments
57. Salmonellosis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
58. Septicemia
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
59. Shigellosis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
60. Staphylococcus Aureus
a. Background
The Genus Taphylococcus
b. Diagnostic Tests
c. Vaccines and Drugs
Prevention
61. Streptococci
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
Group A Streptococci
Group B Streptococci
62. Syphilis
a. Background
b. Diagnostic Tests
Biopsy
Rabbit Infectivity Testing
Other Diagnostic Modalities
c. Vaccines and Drugs
Syphilis and HIV Infection
Syphilis As a Cofactor for HIV Transmission
Basic Science Issues
63. Toxoplasmosis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
64. Trichomonas Vaginalis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
65. Tuberculosis
a. Background
b. Diagnostic Tests
Microscopic Characteristics
Cultural Characteristics
Detection of Antibodies
Skin Tests
MDRTB
c. Vaccines and Drugs
66. Vibrio
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
67. West Nile Virus
a. Background
- Clinical Syndromes
b. Diagnostic Tests
c. Vaccines and Drugs
68. Yersina
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
B. Instrumentation Review and Market Needs
Abbott AxSYM
Abbott IMx/IMx Select
Anagen AN2000/AuraFlex
Siemens Immuno 1
Beckman Coulter Access
BioChem Pharma/SR1
BioMerieux/Vitek Vidas
Biotrol System 7000
Chiron ACS: Centaur
Chiron ACS: 180
Siemens ELISA Processor II/III
Siemens/Opus/Plus/Magnum
Siemens Stratus
JandJ Diagnostics Vitros ECi
JandJ Diagnostics/Amersham Amerlite
Olympus PK310
Roche Elecsys 1010/2010
Roche Cobas Core
Roche ES 300/300AL
Roche ES 22
Roche ES 33
Tosoh AIA-1200/1200DX/NexIA/600
Wallac/Pharmacia Delfia
C. Emerging Diagnostic Technologies
1. DNA Probes
a. Technology Overview
b. Amplification Methods
Polymerase Chain Reaction
- Robotics
- Temperature Cyclers
- PCR Variations
Immuno-PCR
QC-PCR
DAP-PCR
Ligase Chain Reaction
Branched DNA
Q-Beta Replicase
Nucleic-Acid Sequence-Based
Strand Displacement Activation
Self-Sustained Sequence Replicase
2. Monoclonal Antibodies
3. Immunoassays
a. Technological Principle
b. Enzyme Immunoassays (EIA)
Overview
ELISA
Dot Immunobinding Assays
Capillary Immunoassays
Particle-Membrane Capture
Immunoassays
Enzyme Amplification
c. Fluorescent Immunoassays
Fluorescence Polarization
Time-Resolved Pulse Fluorescence
d. Luminescence
Chemiluminescence
Bioluminescence
e. Latex Agglutination
f. Immunoprecipitation
4. Differential Light Scattering
5. Microcomputers and Automation
6. Artificial Intelligence
7. Liposomes
8. Flow Cytometry
9. Chromatography
10. MRI
11. Gel Microdroplets
12. Other
D. Personal Testing
E. Worldwide Business Environment
F. Worldwide Market Structure
G. Worldwide Market Size and Growth
U.K.
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Suppliers
Major Product Development Opportunities
A. Instrumentation
B. Reagent Kits and Test Systems/Panels
C. Computers, Software and Automation
D. Auxiliary Products
Design Criteria for Decentralized Testing Products
Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized
Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
Competitive Assessments
- Abbott
- Affymetrix
- Applera
- Beckman Coulter
- Becton Dickinson
- Binding Site
- Biomerica
- Biokit
- bioMerieux
- Bio-Rad
- Biotrol
- Biosite
- Biotest
- Caliper Technologies
- Cepheid
- Chemicon
- Daiichi
- DiaSorin
- Diagast
- Diamedix
- Digene
- Eiken
- Enzo Biochem
- Fujirebio
- GenBio
- Gene-Tec
- Hemagen
- Immunetics
- Innogenetics
- Inverness
- JandJ
- Meridian
- Nanogen
- Nissui
- Olympus
- Provalis
- Roche
- Saliva Diagnostic
- SeraCare
- Siemens
- Third Wave Technologies
- Thermo Fisher
- Tosho
- Trinity Biotech
- Tropix
- Wampole Labs
- Zenith
- Zeus
Appendix: Assumed Currency Exchange Rates

List of Tables
Major Companies Developing or Marketing AIDS Tests
Major Companies Developing or Marketing Adenovirus
Tests
Major Companies Developing or Marketing Bartonella
Tests
Major Companies Developing or Marketing
Campylobacter Tests
Major Companies Developing or Marketing Candida
Tests
Major Companies Developing or Marketing Chlamydia
Tests
Major Companies Developing or Marketing Clostridium
Tests
Major Companies Developing or Marketing Coronavirus
Tests
Major Companies Developing or Marketing Cryptosporidium
Tests
Major Companies Developing or Marketing CMV Tests
Major Companies Developing or Marketing Echovirus
Tests
Major Companies Developing or Marketing Enterovirus
Tests
Major Companies Developing or Marketing EBV Tests
Major Companies Developing or Marketing Giardia
Tests
Major Companies Developing or Marketing Gonorrhea
Tests
Major Companies Developing or Marketing Hantavirus
Tests
Major Companies Developing or Marketing Helicobacter
Pylori Tests
Major Companies Developing or Marketing Hepatitis
Tests
Major Companies Developing or Marketing Herpes
Tests
Major Companies Developing or Marketing Influenza
Tests
Major Companies Developing or Marketing Legionella
Tests
Major Companies Developing or Marketing Lyme Disease
Tests
Major Companies Developing or Marketing Lymphogranuloma
Tests
Major Companies Developing or Marketing Malaria
Tests
Major Companies Developing or Marketing Measles
Tests
Major Companies Developing or Marketing Meningitis
Tests
Major Companies Developing or Marketing Microsporidium
Tests
Major Companies Developing or Marketing
Mononucleosis Tests
Major Companies Developing or Marketing Mumps Tests
Major Companies Developing or Marketing Mycoplasma
Tests
Major Companies Developing or Marketing Papilloma
Virus Tests
Major Companies Developing or Marketing Parvovirus
Tests
Major Companies Developing or Marketing Pneumonia
Tests
Major Companies Developing or Marketing RSV Tests
Major Companies Developing or Marketing Rotavirus
Tests
Major Companies Developing or Marketing Rubella
Tests
Major Companies Developing or Marketing Salmonella
Tests
Major Companies Developing or Marketing Septicemia
Tests
Major Companies Developing or Marketing Shigella
Tests
Major Companies Developing or Marketing Staphylococci
Tests
Major Companies Developing or Marketing
Streptococci Tests
Major Companies Developing or Marketing Syphilis
Tests
Major Companies Developing or Marketing Toxoplasmosis
Tests
Major Companies Developing or Marketing Trichomonas
Tests
Major Companies Developing or Marketing Tuberculosis
Tests
Major Companies Developing or Marketing West Nile
Tests
Major Companies Developing or Marketing Yersinia Tests
Worldwide All Market Segments Laboratories
Performing Infectious Disease Tests by
Country
Worldwide All Market Segments Total Infectious
Disease Test Volume Forecast by Country
Worldwide All Market Segments Total Infectious
Disease Diagnostics Market Forecast by Country
Infectious Disease Tests Major Issues and Market
Potential For Personal Testing
U.K. Summary Table
All Infectious Diseases Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K.
Laboratories Performing Infectious Disease Tests
by Market Segment
U.K.
Hospital Laboratories Performing Infectious Disease
Tests by Bed Size
U.K.
Commercial/Private Laboratories Performing Infectious
Disease Tests by Annual Test Volume
U.K.
All Market Segments Infectious Disease Test Volume Forecast
U.K.
Hospital Laboratories Infectious Disease Test Volume Forecast
U.K.
Blood Banks Infectious Disease Test Volume Forecast
U.K.
Public Health Laboratories Infectious Disease Test
Volume Forecast
U.K.
Commercial/Private Laboratories Infectious Disease
Test Volume Forecast
U.K.
All Market Segments Infectious Disease Diagnostics
Market Forecast
U.K.
Hospital Laboratories Infectious Disease Diagnostics
Market Forecast
U.K.
Blood Banks Infectious Disease Diagnostics Market Forecast
U.K.
Public Health Laboratories Infectious Disease
Diagnostics Market Forecast
U.K.
Commercial/Private Laboratories Infectious Disease
Diagnostics Market Forecast
U.K.
HIV or HIVI/HIVII Test Volume and Diagnostics Sales
Forecast by Market Segment
U.K.
HTLV I or HTLV I/HTLV II Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K.
HIVAg Test Volume and Diagnostics Sales Forecast by Market
Segment
U.K.
Western Blot/Other Confirmatory Test Volume and
Diagnostics Sales Forecast by Market Segment
U.K.
Adenovirus
Test Volume and Diagnostics Sales Forecast by Market Segment
U.K.
Aeromonads
Test Volume and Diagnostics Sales Forecast by Market Segment
U.K.
BEA
Test Volume and Diagnostics Sales Forecast by Market Segment
U.K.
Blastocystis Hominis Test Volume and Diagnostics Sales
Forecast by Market Segment
U.K.
Campylobacter
Test Volume and Diagnostics Sales Forecast by Market Segment
U.K.
Candida
Test Volume and Diagnostics Sales Forecast by Market Segment
U.K.
Chancroid
Test Volume and Diagnostics Sales Forecast by Market Segment
U.K.
Chlamydia Test Volume and Diagnostics Sales Forecast by Market
Segment
U.K.
Clostridium Test Volume and Diagnostics Sales Forecast by
Market Segment
U.K.
Coronavirus Test Volume and Diagnostics Sales Forecast by
Market Segment
U.K.
Cryptosporidium Test Volume and Diagnostics Sales Forecast by
Market Segment
U.K.
CMV Test Volume and Diagnostics Sales Forecast by Market
Segment
U.K.
E. Coli Test Volume and Diagnostics Sales Forecast by Market
Segment
U.K.
Echovirus Test Volume and Diagnostics Sales Forecast by Market
Segment
U.K.
Enterovirus Test Volume and Diagnostics Sales Forecast by
Market
Segment
U.K.
EBV Test Volume and Diagnostics Sales Forecast by Market
Segment
U.K.
Giardia Test Volume and Diagnostics Sales Forecast by Market
Segment
U.K.
Gonorrhea Test Volume and Diagnostics Sales Forecast by Market
Segment
U.K.
Granuloma Inguinale Test Volume and Diagnostics Sales
Forecast by Market Segment
U.K.
Helicobacter Pylori Test Volume and Diagnostics Sales
Forecast by Market Segment
U.K.
HbsAg Test Volume and Diagnostics Sales Forecast by Market
Segment
U.K.
Hepatitis C Test Volume and Diagnostics Sales Forecast by
Market Segment
U.K.
Anti-HBc Test Volume and Diagnostics Sales Forecast by Market
Segment
U.K.
Anti-HBs Test Volume and Diagnostics Sales Forecast by Market
Segment
U.K.
Anti-HAV Test Volume and Diagnostics Sales Forecast by Market
Segment
U.K.
Hepatitis Delta Test Volume and Diagnostics Sales
Forecast by Market Segment
U.K.
HBcAg Test Volume and Diagnostics Sales Forecast by Market
Segment
U.K.
HBeAg Test Volume and Diagnostics Sales Forecast by Market
Segment
U.K.
ALT/SGPT Test Volume and Diagnostics Sales Forecast by Market
Segment
U.K.
Herpes Simplex I and II Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K.
Influenza Test Volume and Diagnostics Sales Forecast by Market
Segment
U.K.
Legionella Test Volume and Diagnostics Sales Forecast by
Market
Segment
U.K.
Lyme Disease Test Volume and Diagnostics Sales Forecast by
Market Segment
U.K.
Lymphogranuloma Test Volume and Diagnostics Sales Forecast by
Market Segment
U.K.
Malaria Test Volume and Diagnostics Sales Forecast by Market
Segment
U.K.
Measles Test Volume and Diagnostics Sales Forecast by Market
Segment
U.K.
Meningitis Test Volume and Diagnostics Sales Forecast by
Market Segment
U.K.
Microsporidium Test Volume and Diagnostics Sales Forecast by
Market Segment
U.K.
Mononucleosis Test Volume and Diagnostics Sales Forecast by
Market Segment
U.K.
Mumps Test Volume and Diagnostics Sales Forecast by Market
Segment
U.K.
Mycoplasma Test Volume and Diagnostics Sales Forecast by
Market Segment
U.K.
Papilloma Virus Test Volume and Diagnostics Sales Forecast by
Market Segment
U.K.
Parvovirus Test Volume and Diagnostics Sales Forecast by
Market Segment
U.K.
Pneumonia Test Volume and Diagnostics Sales Forecast by
Market Segment
U.K.
Poliomaviruses Test Volume and Diagnostics Sales
Forecast by Market Segment
U.K.
Pseudomonas Test Volume and Diagnostics Sales Forecast by
Market Segment
U.K.
Rabies Test Volume and Diagnostics Sales Forecast by
Market Segment
U.K.
RSV Test Volume and Diagnostics Sales Forecast by Market
Segment
U.K.
Rheumatoid Arthritis Test Volume and Diagnostics
Sales Forecast by Market Segment
U.K.
Rhinovirus Test Volume and Diagnostics Sales Forecast by
Market Segment
U.K.
Rotavirus Test Volume and Diagnostics Sales Forecast by
Market Segment
U.K.
Rubella Test Volume and Diagnostics Sales Forecast by Market
Segment
U.K.
Salmonella Test Volume and Diagnostics Sales Forecast by
Market Segment
U.K.
Scleroderma Test Volume and Diagnostics Sales Forecast by
Market Segment
U.K.
Septicemia Test Volume and Diagnostics Sales Forecast by
Market Segment
U.K.
Shigella Test Volume and Diagnostics Sales Forecast by
Market Segment
U.K.
Staphylococci Test Volume and Diagnostics Sales Forecast by
Market Segment
U.K.
Streptococci Test Volume and Diagnostics Sales Forecast by
Market Segment
U.K.
Syphilis Test Volume and Diagnostics Sales Forecast by
Market Segment
U.K.
Toxoplasmosis Test Volume and Diagnostics Sales Forecast by
Market Segment
U.K.
Trichomonas Test Volume and Diagnostics Sales Forecast by
Market Segment
U.K.
Tuberculosis Test Volume and Diagnostics Sales Forecast by
Market Segment
U.K.
Vibrio Test Volume and Diagnostics Sales Forecast
by Market Segment
U.K.
Yersinia Test Volume and Diagnostics Sales Forecast
by Market Segment
U.K.
AIDS Testing Market Diagnostics Sales by Major
Supplier
U.K.
Campylobacter Testing Market Diagnostics Sales by
Major Supplier
U.K.
Candida Testing Market Diagnostics Sales by Major
Supplier
U.K.
Chlamydia Testing Market Diagnostics Sales by Major
Supplier
U.K.
CMV Testing Market Diagnostics Sales by Major
Supplier
U.K.
EBV Testing Market Diagnostics Sales by Major
Supplier
U.K.
Gonorrhea Testing Market Diagnostics Sales by
Major Supplier
U.K.
Hepatitis Testing Market Diagnostics Sales by Major
Supplier
U.K.
Hepatitis C Testing Market Diagnostics Sales by
Major Supplier
U.K.
Herpes Testing Market Diagnostics Sales by Major
Supplier
U.K.
Meningitis Testing Market Diagnostics Sales by
Major Supplier
U.K.
Mononucleosis Testing Market Diagnostics Sales by
Major Supplier
U.K.
Mycoplasma Testing Market Diagnostics Sales by
Major Supplier
U.K.
Pneumonia Testing Market Diagnostics Sales by Major
Supplier
U.K.
RSV Testing Market Diagnostics Sales by Major Supplier
U.K.
Rheumatoid Arthritis Testing Market Diagnostics
Sales by Major Supplier
U.K.
Rotavirus Testing Market Diagnostics Sales by
Major Supplier
U.K.
Rubella Testing Market Diagnostics Sales by Major
Supplier
U.K.
Septicemia Testing Market Diagnostics Sales by Major
Supplier
U.K.
Shigella Testing Market Diagnostics Sales by Major
Supplier
U.K.
Streptocci Testing Market Diagnostics Sales by
Major Supplier
U.K.
Syphilis Testing MarketDiagnostics Sales by Major
Supplier
U.K.
Toxoplasmosis Testing Market Diagnostics Sales by
Major Supplier
U.K.
Trichomonas Testing Market Diagnostics Sales by
Major Supplier
U.K.
Tuberculosis Testing Market Diagnostics Sales by
Major Supplier
U.K.
Infectious Disease Diagnostic Testing Instrumentation
Major Systems Estimated Placements and Installed Base

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers

New Frontiers in Automated Microbiology: Global Challenges, Emerging Technologies, Competitive Landscape

New Frontiers in Automated Microbiology: Global Challenges, Emerging Technologies, Competitive Landscape

  • $ 21 100
  • Industry report
  • May 2014
  • by Venture Planning Group

“New Frontiers in Automated Microbiology: Global Challenges, Emerging Technologies, Competitive Landscape” is Venture Planning Group's new seven-country strategic analysis of the major business opportunities ...

Emerging Opportunities in the Global Virology and Bacteriology Testing Market

Emerging Opportunities in the Global Virology and Bacteriology Testing Market

  • $ 21 100
  • Industry report
  • June 2014
  • by Venture Planning Group

“Emerging Opportunities in the Global Virology and Bacteriology Testing Market” is a new seven-country strategic analysis of major business opportunities emerging in the infectious disease testing ...

New Frontiers in Coagulation Testing: Global Challenges, Emerging Technologies, Competitive Landscape

New Frontiers in Coagulation Testing: Global Challenges, Emerging Technologies, Competitive Landscape

  • $ 21 100
  • Industry report
  • May 2014
  • by Venture Planning Group

“New Frontiers in Coagulation Testing: Global Challenges, Emerging Technologies, Competitive Landscape” is Venture Planning Group's new seven-country report designed to help current suppliers and potential ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.